ELAN vs RDY: stock comparison and AI forecast
Elanco Animal Health Inc (ELAN) and Dr Reddys Laboratories Ltd (RDY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ELAN Elanco Animal Health Inc
- Market Cap
- $12.04B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
RDY Dr Reddys Laboratories Ltd
- Market Cap
- $11.83B
- P/E Ratio
- 15.6x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ELAN and RDY have similar market capitalizations ($12.04B and $11.83B).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ELAN | RDY |
|---|---|---|
| Market Cap | $12.04B | $11.83B |
| P/E Ratio | – | 15.56x |
| P/B Ratio | 1.83x | – |
| EPS | $-0.38 | $0.91 |
| Book Value/Share | $13.19 | – |
| Revenue/Share | $10.05 | $4.74 |
| FCF/Share | $0.76 | $0.28 |
Profitability & Margins
| Metric | ELAN | RDY |
|---|---|---|
| ROE | -3.0% | – |
| ROA | -1.5% | – |
| Gross Margin | 55.4% | 58.4% |
| Operating Margin | – | 22.0% |
| Net Margin | -4.0% | – |
| EBT Margin | -3.3% | 23.6% |
| Tax Rate | -19.9% | 25.4% |
Financial Health
| Metric | ELAN | RDY |
|---|---|---|
| Current Ratio | 2.05x | – |
| Quick Ratio | 1.10x | – |
| D/E Ratio | 1.06x | – |
| Financial Leverage | 2.06x | – |
| Working Capital | $1.95B | – |
Cash Flow
| Metric | ELAN | RDY |
|---|---|---|
| Operating Cash Flow | $617M | $569M |
| Free Cash Flow | $379M | $237M |
| Capital Spending | -$238M | -$332M |
| OCF Growth YoY | 7.9% | – |
| FCF Growth YoY | 5.0% | 0.0% |
| FCF/Sales | 7.5% | 6.0% |
| CapEx/Sales | 4.7% | 8.4% |
Operational Efficiency
| Metric | ELAN | RDY |
|---|---|---|
| Asset Turnover | 0.37x | – |
| Receivables Turnover | 4.7x | – |
| Inventory Turnover | 1.3x | – |
| Fixed Assets Turnover | 3.6x | – |
| Days Sales Outstanding | 78 days | – |
| Days Inventory | 288 days | – |
| Payables Period | 70 days | – |
| Cash Conversion Cycle | 297 days | – |
Income Statement
| Metric | ELAN | RDY |
|---|---|---|
| Total Revenue | $5.02B | $3.96B |
| Operating Income | – | $872M |
| Net Income | -$199M | – |
| R&D Expense | $371M | $333M |
| SG&A Expense | $1.52B | $1.14B |
| Cost of Goods Sold | $2.24B | $1.65B |
Dividend & Shareholder Information
| Metric | ELAN | RDY |
|---|---|---|
| Shares Outstanding | 500M | 835M |
| Net Income Growth | -145.8% | – |
| EPS Growth | -147.5% | – |
ELAN vs RDY: stock comparison and AI forecast
Which is bigger, ELAN or RDY?
ELAN and RDY have similar market capitalizations ($12.04B and $11.83B).
Which one does Intratio's AI model rank higher, ELAN or RDY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.